Cargando…
Dupilumab efficacy and biomarkers in chronic rhinosinusitis with nasal polyps: Association between dupilumab treatment effect on nasal polyp score and biomarkers of type 2 inflammation in patients with chronic rhinosinusitis with nasal polyps in the phase 3 SINUS‐24 and SINUS‐52 trials
| Autores principales: | , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9544911/ https://www.ncbi.nlm.nih.gov/pubmed/34970860 http://dx.doi.org/10.1002/alr.22964 |
| _version_ | 1784804703411896320 |
|---|---|
| author | Bachert, Claus Corren, Jonathan Lee, Stella E. Zhang, Haixin Harel, Sivan Cunoosamy, Danen Khan, Asif H. Jacob‐Nara, Juby A. Siddiqui, Shahid Nash, Scott Rowe, Paul J. Deniz, Yamo |
| author_facet | Bachert, Claus Corren, Jonathan Lee, Stella E. Zhang, Haixin Harel, Sivan Cunoosamy, Danen Khan, Asif H. Jacob‐Nara, Juby A. Siddiqui, Shahid Nash, Scott Rowe, Paul J. Deniz, Yamo |
| author_sort | Bachert, Claus |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9544911 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | John Wiley and Sons Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-95449112022-10-14 Dupilumab efficacy and biomarkers in chronic rhinosinusitis with nasal polyps: Association between dupilumab treatment effect on nasal polyp score and biomarkers of type 2 inflammation in patients with chronic rhinosinusitis with nasal polyps in the phase 3 SINUS‐24 and SINUS‐52 trials Bachert, Claus Corren, Jonathan Lee, Stella E. Zhang, Haixin Harel, Sivan Cunoosamy, Danen Khan, Asif H. Jacob‐Nara, Juby A. Siddiqui, Shahid Nash, Scott Rowe, Paul J. Deniz, Yamo Int Forum Allergy Rhinol Research Notes John Wiley and Sons Inc. 2022-01-31 2022-09 /pmc/articles/PMC9544911/ /pubmed/34970860 http://dx.doi.org/10.1002/alr.22964 Text en © 2022 Sanofi Genzyme. International Forum of Allergy & Rhinology published by Wiley Periodicals LLC on behalf of American Academy of Otolaryngic Allergy and American Rhinologic Society. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
| spellingShingle | Research Notes Bachert, Claus Corren, Jonathan Lee, Stella E. Zhang, Haixin Harel, Sivan Cunoosamy, Danen Khan, Asif H. Jacob‐Nara, Juby A. Siddiqui, Shahid Nash, Scott Rowe, Paul J. Deniz, Yamo Dupilumab efficacy and biomarkers in chronic rhinosinusitis with nasal polyps: Association between dupilumab treatment effect on nasal polyp score and biomarkers of type 2 inflammation in patients with chronic rhinosinusitis with nasal polyps in the phase 3 SINUS‐24 and SINUS‐52 trials |
| title | Dupilumab efficacy and biomarkers in chronic rhinosinusitis with nasal polyps: Association between dupilumab treatment effect on nasal polyp score and biomarkers of type 2 inflammation in patients with chronic rhinosinusitis with nasal polyps in the phase 3 SINUS‐24 and SINUS‐52 trials |
| title_full | Dupilumab efficacy and biomarkers in chronic rhinosinusitis with nasal polyps: Association between dupilumab treatment effect on nasal polyp score and biomarkers of type 2 inflammation in patients with chronic rhinosinusitis with nasal polyps in the phase 3 SINUS‐24 and SINUS‐52 trials |
| title_fullStr | Dupilumab efficacy and biomarkers in chronic rhinosinusitis with nasal polyps: Association between dupilumab treatment effect on nasal polyp score and biomarkers of type 2 inflammation in patients with chronic rhinosinusitis with nasal polyps in the phase 3 SINUS‐24 and SINUS‐52 trials |
| title_full_unstemmed | Dupilumab efficacy and biomarkers in chronic rhinosinusitis with nasal polyps: Association between dupilumab treatment effect on nasal polyp score and biomarkers of type 2 inflammation in patients with chronic rhinosinusitis with nasal polyps in the phase 3 SINUS‐24 and SINUS‐52 trials |
| title_short | Dupilumab efficacy and biomarkers in chronic rhinosinusitis with nasal polyps: Association between dupilumab treatment effect on nasal polyp score and biomarkers of type 2 inflammation in patients with chronic rhinosinusitis with nasal polyps in the phase 3 SINUS‐24 and SINUS‐52 trials |
| title_sort | dupilumab efficacy and biomarkers in chronic rhinosinusitis with nasal polyps: association between dupilumab treatment effect on nasal polyp score and biomarkers of type 2 inflammation in patients with chronic rhinosinusitis with nasal polyps in the phase 3 sinus‐24 and sinus‐52 trials |
| topic | Research Notes |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9544911/ https://www.ncbi.nlm.nih.gov/pubmed/34970860 http://dx.doi.org/10.1002/alr.22964 |
| work_keys_str_mv | AT bachertclaus dupilumabefficacyandbiomarkersinchronicrhinosinusitiswithnasalpolypsassociationbetweendupilumabtreatmenteffectonnasalpolypscoreandbiomarkersoftype2inflammationinpatientswithchronicrhinosinusitiswithnasalpolypsinthephase3sinus24andsinus52trials AT correnjonathan dupilumabefficacyandbiomarkersinchronicrhinosinusitiswithnasalpolypsassociationbetweendupilumabtreatmenteffectonnasalpolypscoreandbiomarkersoftype2inflammationinpatientswithchronicrhinosinusitiswithnasalpolypsinthephase3sinus24andsinus52trials AT leestellae dupilumabefficacyandbiomarkersinchronicrhinosinusitiswithnasalpolypsassociationbetweendupilumabtreatmenteffectonnasalpolypscoreandbiomarkersoftype2inflammationinpatientswithchronicrhinosinusitiswithnasalpolypsinthephase3sinus24andsinus52trials AT zhanghaixin dupilumabefficacyandbiomarkersinchronicrhinosinusitiswithnasalpolypsassociationbetweendupilumabtreatmenteffectonnasalpolypscoreandbiomarkersoftype2inflammationinpatientswithchronicrhinosinusitiswithnasalpolypsinthephase3sinus24andsinus52trials AT harelsivan dupilumabefficacyandbiomarkersinchronicrhinosinusitiswithnasalpolypsassociationbetweendupilumabtreatmenteffectonnasalpolypscoreandbiomarkersoftype2inflammationinpatientswithchronicrhinosinusitiswithnasalpolypsinthephase3sinus24andsinus52trials AT cunoosamydanen dupilumabefficacyandbiomarkersinchronicrhinosinusitiswithnasalpolypsassociationbetweendupilumabtreatmenteffectonnasalpolypscoreandbiomarkersoftype2inflammationinpatientswithchronicrhinosinusitiswithnasalpolypsinthephase3sinus24andsinus52trials AT khanasifh dupilumabefficacyandbiomarkersinchronicrhinosinusitiswithnasalpolypsassociationbetweendupilumabtreatmenteffectonnasalpolypscoreandbiomarkersoftype2inflammationinpatientswithchronicrhinosinusitiswithnasalpolypsinthephase3sinus24andsinus52trials AT jacobnarajubya dupilumabefficacyandbiomarkersinchronicrhinosinusitiswithnasalpolypsassociationbetweendupilumabtreatmenteffectonnasalpolypscoreandbiomarkersoftype2inflammationinpatientswithchronicrhinosinusitiswithnasalpolypsinthephase3sinus24andsinus52trials AT siddiquishahid dupilumabefficacyandbiomarkersinchronicrhinosinusitiswithnasalpolypsassociationbetweendupilumabtreatmenteffectonnasalpolypscoreandbiomarkersoftype2inflammationinpatientswithchronicrhinosinusitiswithnasalpolypsinthephase3sinus24andsinus52trials AT nashscott dupilumabefficacyandbiomarkersinchronicrhinosinusitiswithnasalpolypsassociationbetweendupilumabtreatmenteffectonnasalpolypscoreandbiomarkersoftype2inflammationinpatientswithchronicrhinosinusitiswithnasalpolypsinthephase3sinus24andsinus52trials AT rowepaulj dupilumabefficacyandbiomarkersinchronicrhinosinusitiswithnasalpolypsassociationbetweendupilumabtreatmenteffectonnasalpolypscoreandbiomarkersoftype2inflammationinpatientswithchronicrhinosinusitiswithnasalpolypsinthephase3sinus24andsinus52trials AT denizyamo dupilumabefficacyandbiomarkersinchronicrhinosinusitiswithnasalpolypsassociationbetweendupilumabtreatmenteffectonnasalpolypscoreandbiomarkersoftype2inflammationinpatientswithchronicrhinosinusitiswithnasalpolypsinthephase3sinus24andsinus52trials |